XML 45 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of weighted average assumptions
We utilized the Black-Scholes option valuation model with the following weighted average assumptions:
 
 
Nine Months Ended
March 31,
 
2017
 
2016
Risk-free interest rate
1.1
%
 
1.4
%
Expected dividend yield
0.0
%
 
0.0
%
Expected life (in years)
4.6

 
4.7

Expected volatility factor
31.4
%
 
34.1
%
Schedule of stock-based compensation expense
The stock-based compensation expense under all equity plans and its classification in the unaudited consolidated statements of operations for the three and nine months ended March 31, 2017 and 2016 are as follows:
 
 
Three Months Ended
March 31,
 
Nine Months Ended
March 31,
 
2017
 
2016
 
2017
 
2016
 
(Dollars in Thousands)
Recorded as expenses:
 

 
 

 
 

 
 

Cost of services and other
$
363

 
$
343

 
$
1,106

 
$
1,049

Selling and marketing
972

 
1,797

 
2,937

 
3,547

Research and development
1,618

 
871

 
4,177

 
2,543

General and administrative
1,724

 
1,367

 
6,087

 
5,174

Total stock-based compensation
$
4,677

 
$
4,378

 
$
14,307

 
$
12,313

Schedule of stock option and RSU activity
A summary of stock option and RSU activity under all equity plans for the three and nine months ended March 31, 2017 is as follows:
 
 
Stock Options
 
Restricted Stock Units
 
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic Value
(in 000’s)
 
Shares
 
Weighted
Average
Grant Date
Fair Value
Outstanding at June 30, 2016
1,314,142

 
$
32.47

 
7.23
 
$
12,340

 
493,332

 
$
41.06

Granted
459,785

 
45.54

 
 
 
 

 
511,777

 
45.98

Settled (RSUs)

 
 

 
 
 
 

 
(239,909
)
 
41.67

Exercised
(295,059
)
 
26.99

 
 
 
 

 

 
 

Cancelled / Forfeited
(46,024
)
 
39.58

 
 
 
 

 
(39,191
)
 
42.40

Outstanding at March 31, 2017
1,432,844

 
$
37.57

 
7.59
 
$
30,597

 
726,009

 
$
44.25

Vested and exercisable at March 31, 2017
777,059

 
$
32.29

 
6.53
 
$
20,695

 

 
 

Vested and expected to vest as of March 31, 2017
1,369,672

 
$
37.25

 
7.53
 
$
29,686

 
655,472

 
$
44.16